Structural Triage Live Backend Gates

Controlled public-alpha operating evidence service validation for Structural Triage Structural Triage.

Latest gate result: PASS. Structural Triage passed a 1,000-target source-available live persistent evidence service gate. This validates evidence service operation, persistence, artifact generation, evidence artifact proxying, and ranked structural-triage output. It is not biological validation.
Latest gate
1,000 targets
Completed
1000 / 1000
Failed
0
Failure rate
0.000000
Artifact files
7,002
GateRequestedCompletedFailedResultMeaning
100-target evidence service gate1001000PASSControlled public-alpha evidence service gate
250-target evidence service gate2502500PASSSmall-panel pilot candidate gate
1,000-target evidence service gate100010000PASSSerious researcher-pilot candidate gate

Runtime path

  • Website: protein.neoamorfic.ai
  • Gateway: website gateway routes
  • Worker: stage1-worker.neoamorfic.ai
  • Service: protein-stage1-worker.service
  • Mode: persistent_stage1_worker

1,000-gate action summary

  • open_first: 209
  • review_after_top_set: 259
  • archive_or_later_review: 532

1,000-gate top-ranked examples

RankTargetAccessionActionScorepLDDT < 70pLDDT < 50
1ODAM_A1E959A1E959open_first1001.00.824373
2MEIOC_A2RUB1A2RUB1open_first1000.8382350.801471
3BDP1_A6H8Y1A6H8Y1open_first1000.9474090.917302
4PALM3_A6NDB9A6NDB9open_first1000.8618130.72214
5RBMY1B_A6NDE4A6NDE4open_first1000.8407260.715726
6PCARE_A6NGG8A6NGG8open_first1000.8928570.819876
7ARHGAP32_A7KAX9A7KAX9open_first1000.812650.769046
8SRRM4_A7MD48A7MD48open_first1000.9328970.705401
9POM121C_A8CG34A8CG34open_first1000.9316520.857608
10FBXW7-AS1_B0L3A2B0L3A2open_first1001.00.870588
11BCL9_O00512O00512open_first1000.9347830.859748
12DLGAP1_O14490O14490open_first1000.838280.70522

Scope notes

These gates validate operating evidence service operation, persistence, artifact generation, evidence artifact proxying, and ranked structural-triage output. They do not validate biological truth, protein stability, binding, inhibitor relevance, clinical use, or regulated decision support.